Mesenchymal stem cells suppress B-cell terminal differentiation.

Area of Science:

• Immunology
• Cell Biology
• Stem Cell Research

Background:

• Mesenchymal stem cells (MSCs) exhibit immunomodulatory effects on various immune cells.
• The precise impact of MSCs on B lymphocytes and the underlying mechanisms remain incompletely understood.

Purpose of the Study:

• To investigate the modulatory effects of MSCs on B-cell differentiation.
• To identify the role of MSC-derived humoral factors in B-cell gene regulation.

Main Methods:

• Co-culture of mouse bone marrow-derived MSCs with purified splenic B cells using a transwell system.
• In vitro stimulation of B cells with lipopolysaccharide (LPS) and in vivo stimulation with T-dependent and T-independent antigens.
• Analysis of B-cell proliferation, apoptosis, differentiation markers (CD138), IgM production, and B-lymphocyte-induced maturation protein-1 (BLIMP-1) mRNA expression.

Main Results:

• MSC co-culture suppressed LPS-stimulated B-cell proliferation and reduced CD138(+) plasma cell percentages.
• MSC co-culture led to increased IgM(+) B cells but decreased secreted IgM, suggesting impaired terminal differentiation.
• MSC-conditioned media inhibited B-cell terminal differentiation in vitro and suppressed antigen-specific IgM and IgG1 secretion in vivo, correlating with reduced BLIMP-1 mRNA expression.

Conclusions:

• Humoral factors secreted by MSCs suppress B-cell terminal differentiation.
• This suppression may be mediated by the inhibition of BLIMP-1 expression.
• The specific MSC-derived factors responsible for this immunomodulatory effect require further identification.